Vitafoods Europe 2026: Tosla and Geltor launch vegan collagen beauty shot

Liquid nutraceutical supplier Tosla has launched a Signaling Collagen Shot in partnership with biotechnology company Geltor. The ready-to-market liquid supplement will feature at the upcoming Vitafoods Europe 2026 trade fair in Barcelona, Spain (May 5–7). 

The vegan, ready-to-drink Signaling Collagen Shot was created through Geltor’s expertise in biodesigned peptides and proteins, along with Tosla’s specialty in designing liquid ingredients for longevity-focused supplementation.

The formula features Geltor’s “ultra-potent” and clinically backed US FDA-cleared PrimaColl, a biomimetic vegan type 21 signaling collagen polypeptide. This rare collagen type can only be produced through biotech. It is paired with Tosla’s Velious Flavor Technology that conceals unwanted tastes of active ingredients in supplements.

Velious Flavor Technology also features in several of Tosla’s other products, including its Lumina365 skin care offering and HairCycle+.

Signaling Collagen Shot is available as a 30 mL daily liquid supplement in a cherry-raspberry flavor, featuring 1 g of PrimaColl per bottle.

“Tosla was built on the belief that efficacy alone is not enough — ritual drives results,” says Uroš Gotar, chief innovations officer.

“Our partnership with Geltor brings together breakthrough biotechnology and sensorial design in a way that feels seamless in daily life. With PrimaColl, we are transforming advanced science into an experience consumers can look forward to, because when wellness becomes a ritual, adherence follows, and results are realized over time.”

PrimaColl’s targeted skin benefits

PrimaColl has FDA generally recognized as safe (GRAS) status, but is not currently authorized for use in food supplements in the EU and UK, and may require pre-market authorization in Canada.

The ingredient delivers targeted skin benefits designed to support key skin-signaling pathways and improve the appearance of skin.

PrimaColl delivers targeted skin benefits designed to support key skin-signaling pathways and improve the appearance of skin.PrimaColl was evaluated in a randomized, double-blind, placebo-controlled clinical study of 170 women over 12 weeks. In the study, which is not yet published, 80–92% of participants showed improvements in skin firmness, elasticity, moisturization, and wrinkle depth who consumed 1–2.5 g daily.

“Biodesigned ingredients like PrimaColl represent an evolution in collagen science, but innovation means nothing if it doesn’t reach consumers,” says Alex Lorestani, CEO and co-founder of Geltor.

“Our partnership with Tosla bridges that gap, transforming breakthrough biotechnology into a ready-to-market solution that brands can confidently launch. This collaboration proves that when you unite ingredient innovation with formulation expertise, you create something consumers actually want to use every day.”

Vitafoods Europe 2026 innovations

In other Vitafoods Europe 2026 showcases set to debut next month, nutraceutical ingredient specialist DolCas Biotech will unveil a new sachet format of its neutral odor and flavor marine collagen tripeptide ingredient, Morikol.

Meanwhile, Pharmactive Biotech Products plans to showcase its first nutricosmetic, Kyoh, which is made from rocket leaf extract to help support hair follicle function.

In digestive wellness, Greenvit will exhibit its Aronvit gut health nutraceutical that offers prebiotic effects from aronia berry polyphenols, as well as a dual benefit when serving as a low-dose modulator of natural GLP-1 for metabolism.